• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1D NMR WaterLOGSY 作为一种基于片段的药物发现的有效方法。

1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery.

机构信息

a Université de Lyon, CNRS, Université Claude Bernard Lyon 1, ENS Lyon, CRMN FRE 2034 , Villeurbanne , France.

b Université de Lyon, Université Claude Bernard Lyon 1, Faculté de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Santé Lyon-Est CNRS UMS3453 - INSERM US7 , Lyon , France.

出版信息

J Enzyme Inhib Med Chem. 2019 Dec;34(1):1218-1225. doi: 10.1080/14756366.2019.1636235.

DOI:10.1080/14756366.2019.1636235
PMID:31286785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6691826/
Abstract

WaterLOGSY is a sensitive ligand-observed NMR experiment for detection of interaction between a ligand and a protein and is now well-established as a screening technique for fragment-based lead discovery. Here we develop and assess a protocol to derive ligand epitope mapping from WaterLOGSY data and demonstrate its general applicability in studies of fragment-sized ligands binding to six different proteins (glycogen phosphorylase, protein peroxiredoxin 5, Bcl-x, Mcl-1, HSP90, and human serum albumin). We compare the WaterLOGSY results to those obtained from the more widely used saturation transfer difference experiments and to the 3D structures of the complexes when available. In addition, we evaluate the impact of ligand labile protons on the WaterLOGSY data. Our results demonstrate that the WaterLOGSY experiment can be used as an additional confirmation of the binding mode of a ligand to a protein.

摘要

WaterLOGSY 是一种灵敏的配体观察 NMR 实验,用于检测配体与蛋白质之间的相互作用,现已成为基于片段的先导化合物发现的筛选技术。在这里,我们开发并评估了一种从 WaterLOGSY 数据中得出配体表位图谱的方案,并证明其在研究与六种不同蛋白质(糖原磷酸化酶、蛋白过氧化物酶 5、Bcl-x、Mcl-1、HSP90 和人血清白蛋白)结合的片段大小配体中的普遍适用性。我们将 WaterLOGSY 结果与更广泛使用的饱和转移差异实验的结果以及复合物的 3D 结构进行比较(当有可用结构时)。此外,我们还评估了配体不稳定质子对 WaterLOGSY 数据的影响。我们的结果表明,WaterLOGSY 实验可用作配体与蛋白质结合模式的附加确认。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/859453e87b3a/IENZ_A_1636235_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/e2a31883741d/IENZ_A_1636235_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/d6bb7a5860fd/IENZ_A_1636235_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/aca58b08150d/IENZ_A_1636235_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/21b972e5b7ed/IENZ_A_1636235_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/3940b60a3e3a/IENZ_A_1636235_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/0189aa2d7150/IENZ_A_1636235_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/0f3a6c902050/IENZ_A_1636235_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/859453e87b3a/IENZ_A_1636235_F0008_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/e2a31883741d/IENZ_A_1636235_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/d6bb7a5860fd/IENZ_A_1636235_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/aca58b08150d/IENZ_A_1636235_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/21b972e5b7ed/IENZ_A_1636235_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/3940b60a3e3a/IENZ_A_1636235_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/0189aa2d7150/IENZ_A_1636235_F0006_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/0f3a6c902050/IENZ_A_1636235_F0007_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ba/6691826/859453e87b3a/IENZ_A_1636235_F0008_C.jpg

相似文献

1
1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery.1D NMR WaterLOGSY 作为一种基于片段的药物发现的有效方法。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1218-1225. doi: 10.1080/14756366.2019.1636235.
2
[NMR screening in fragment-based drug discovery].基于片段的药物发现中的核磁共振筛选
Yakugaku Zasshi. 2010 Mar;130(3):325-33. doi: 10.1248/yakushi.130.325.
3
Aroma WaterLOGSY: a fast and sensitive screening tool for drug discovery.芳水 LOGSY:一种快速灵敏的药物发现筛选工具。
Magn Reson Chem. 2010 Dec;48(12):909-11. doi: 10.1002/mrc.2692.
4
Protein-Small Molecule Interactions by WaterLOGSY.基于水LOGSY的蛋白质-小分子相互作用
Methods Enzymol. 2019;615:477-500. doi: 10.1016/bs.mie.2018.08.020. Epub 2018 Sep 20.
5
Application of NMR screening techniques for observing ligand binding with a protein receptor.应用核磁共振筛选技术观察配体与蛋白质受体的结合。
Magn Reson Chem. 2005 Jan;43(1):69-72. doi: 10.1002/mrc.1492.
6
Time efficient detection of protein-ligand interactions with the polarization optimized PO-WaterLOGSY NMR experiment.利用极化优化的PO-WaterLOGSY核磁共振实验高效检测蛋白质-配体相互作用。
J Biomol NMR. 2009 Apr;43(4):211-7. doi: 10.1007/s10858-009-9303-5. Epub 2009 Feb 11.
7
1D and 2D NMR for KRAS:Ligand Binding.1D 和 2D NMR 研究 KRAS:配体结合。
Methods Mol Biol. 2024;2797:115-124. doi: 10.1007/978-1-0716-3822-4_9.
8
NMR in drug design.核磁共振在药物设计中的应用
Arch Biochem Biophys. 2017 Aug 15;628:132-147. doi: 10.1016/j.abb.2017.06.005. Epub 2017 Jun 13.
9
Interaction of lafutidine in binding to human serum albumin in gastric ulcer therapy: STD-NMR, WaterLOGSY-NMR, NMR relaxation times, Tr-NOESY, molecule docking, and spectroscopic studies.雷贝拉唑在胃溃疡治疗中与人血清白蛋白结合的相互作用:STD-NMR、WaterLOGSY-NMR、NMR弛豫时间、Tr-NOESY、分子对接及光谱研究
Arch Biochem Biophys. 2016 Sep 15;606:81-9. doi: 10.1016/j.abb.2016.07.016. Epub 2016 Jul 22.
10
Protocol to perform fragment screening using NMR spectroscopy.使用 NMR 光谱进行碎片筛选的方案。
STAR Protoc. 2024 Sep 20;5(3):103278. doi: 10.1016/j.xpro.2024.103278. Epub 2024 Aug 22.

引用本文的文献

1
Targeting the SARS-CoV-2 RNA Translation Initiation Element SL1 by Molecules of Low Molecular Weight.利用低分子量分子靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)RNA翻译起始元件SL1
J Am Chem Soc. 2025 Aug 13;147(32):28783-28798. doi: 10.1021/jacs.5c05264. Epub 2025 Aug 4.
2
NMR in the Age of Modern Biomedical Research and Drug Discovery.现代生物医学研究与药物发现时代的核磁共振技术
J Mol Biol. 2025 Jun 23:169302. doi: 10.1016/j.jmb.2025.169302.
3
Target Engagement Assays in Early Drug Discovery.早期药物发现中的靶点结合分析

本文引用的文献

1
Protein-Small Molecule Interactions by WaterLOGSY.基于水LOGSY的蛋白质-小分子相互作用
Methods Enzymol. 2019;615:477-500. doi: 10.1016/bs.mie.2018.08.020. Epub 2018 Sep 20.
2
Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy.通过饱和转移差核磁共振波谱法对配体结合进行表征
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1784-1788. doi: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q.
3
Direct NMR Probing of Hydration Shells of Protein Ligand Interfaces and Its Application to Drug Design.
J Med Chem. 2025 Jun 26;68(12):12331-12368. doi: 10.1021/acs.jmedchem.4c03115. Epub 2025 Jun 4.
4
Chemically induced partial unfolding of the multifunctional apurinic/apyrimidinic endonuclease 1.化学诱导多功能脱嘌呤/脱嘧啶核酸内切酶1的部分去折叠
Protein Sci. 2025 Jun;34(6):e70148. doi: 10.1002/pro.70148.
5
Small molecules reveal differential shifts in stability and protein binding for G-quadruplex RNA.小分子揭示了G-四链体RNA在稳定性和蛋白质结合方面的差异变化。
bioRxiv. 2025 Feb 12:2025.02.10.637408. doi: 10.1101/2025.02.10.637408.
6
Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug.2型糖尿病药物卡格列净对淀粉样蛋白形成和多态性的动力学调控
J Am Chem Soc. 2025 Apr 9;147(14):11859-11878. doi: 10.1021/jacs.4c16743. Epub 2025 Feb 21.
7
9,10-Bis[(4-(2-hydroxyethyl)piperazine-1-yl)prop2-yne-1-yl]anthracene: G-Quadruplex Selectivity and Anticancer Activity.9,10-双[(4-(2-羟乙基)哌嗪-1-基)丙-2-炔-1-基]蒽:G-四链体选择性与抗癌活性
ACS Med Chem Lett. 2024 Aug 21;15(9):1615-1619. doi: 10.1021/acsmedchemlett.4c00340. eCollection 2024 Sep 12.
8
Gonococcal Mimitope Vaccine Candidate Forms a Beta-Hairpin Turn and Binds Hydrophobically to a Therapeutic Monoclonal Antibody.淋病奈瑟菌模拟表位候选疫苗形成β-发夹结构并通过疏水作用与治疗性单克隆抗体结合。
JACS Au. 2024 Jul 5;4(7):2617-2629. doi: 10.1021/jacsau.4c00359. eCollection 2024 Jul 22.
9
1D and 2D NMR for KRAS:Ligand Binding.1D 和 2D NMR 研究 KRAS:配体结合。
Methods Mol Biol. 2024;2797:115-124. doi: 10.1007/978-1-0716-3822-4_9.
10
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.新型 Ref-1/APE1 靶向抑制剂在多种癌症类型的临床应用中显示出更高的效力。
Pharmacol Res. 2024 Mar;201:107092. doi: 10.1016/j.phrs.2024.107092. Epub 2024 Feb 2.
直接核磁共振探测蛋白配体界面的水合壳及其在药物设计中的应用。
J Med Chem. 2017 Nov 9;60(21):8708-8715. doi: 10.1021/acs.jmedchem.7b00845. Epub 2017 Oct 1.
4
NMR in drug design.核磁共振在药物设计中的应用
Arch Biochem Biophys. 2017 Aug 15;628:132-147. doi: 10.1016/j.abb.2017.06.005. Epub 2017 Jun 13.
5
Evaluation of ligand-based NMR screening methods to characterize small molecule binding to HIV-1 glycoprotein-41.基于配体的核磁共振筛选方法用于表征小分子与HIV-1糖蛋白-41结合的评估。
Org Biomol Chem. 2017 Jun 28;15(24):5210-5219. doi: 10.1039/c7ob00954b. Epub 2017 Jun 7.
6
Protein-ligand binding affinity determination by the waterLOGSY method: An optimised approach considering ligand rebinding.用水LOGSY 方法测定蛋白质-配体结合亲和力:考虑配体再结合的优化方法。
Sci Rep. 2017 Mar 3;7:43727. doi: 10.1038/srep43727.
7
NMR WaterLOGSY Reveals Weak Binding of Bisphenol A with Amyloid Fibers of a Conserved 11 Residue Peptide from Androgen Receptor.核磁共振氢谱水LOGSY揭示双酚A与雄激素受体保守的11个残基肽的淀粉样纤维的弱结合。
PLoS One. 2016 Sep 1;11(9):e0161948. doi: 10.1371/journal.pone.0161948. eCollection 2016.
8
Twenty years on: the impact of fragments on drug discovery.二十年后:碎片对药物发现的影响。
Nat Rev Drug Discov. 2016 Sep;15(9):605-619. doi: 10.1038/nrd.2016.109. Epub 2016 Jul 15.
9
Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.病毒样颗粒(VLP)在病毒膜蛋白相互作用的核磁共振表征中的应用。
J Biomol NMR. 2016 Mar;64(3):255-65. doi: 10.1007/s10858-016-0025-1. Epub 2016 Feb 26.
10
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.在复发的慢性淋巴细胞白血病中使用维奈托克靶向BCL2
N Engl J Med. 2016 Jan 28;374(4):311-22. doi: 10.1056/NEJMoa1513257. Epub 2015 Dec 6.